First human test for new drug begins
NCT ID NCT07075640
Summary
This is the first study in people for a new drug called AG-236. Its main goal is to check if a single injection is safe and well-tolerated in healthy volunteers. Researchers will also measure how the drug moves through and leaves the body. The results will help decide if AG-236 can be tested further in future studies for specific diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit Inc.
RECRUITINGMadison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.